Correlation Between Morgan Stanley and Foresee Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Foresee Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Foresee Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Foresee Pharmaceuticals Co, you can compare the effects of market volatilities on Morgan Stanley and Foresee Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Foresee Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Foresee Pharmaceuticals.

Diversification Opportunities for Morgan Stanley and Foresee Pharmaceuticals

-0.01

Correlation Coefficient

Morgan Stanley  Foresee Pharmaceuticals

Good diversification

The 3 months correlation between Morgan and Foresee is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Foresee Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foresee Pharmaceuticals and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Foresee Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foresee Pharmaceuticals has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Foresee Pharmaceuticals go up and down completely randomly.

Pair Corralation between Morgan Stanley and Foresee Pharmaceuticals

Given the investment horizon of 90 days Morgan Stanley Direct is expected to under-perform the Foresee Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Morgan Stanley Direct is 1.28 times less risky than Foresee Pharmaceuticals. The stock trades about -0.15 of its potential returns per unit of risk. The Foresee Pharmaceuticals Co is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest  7,730  in Foresee Pharmaceuticals Co on December 4, 2024 and sell it today you would earn a total of  770.00  from holding Foresee Pharmaceuticals Co or generate 9.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Morgan Stanley Direct  vs.  Foresee Pharmaceuticals Co

Morgan Stanley Direct

Risk-Adjusted Performance

Very Weak

Over the last 90 days Morgan Stanley Direct has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Foresee Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Foresee Pharmaceuticals Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Foresee Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Morgan Stanley and Foresee Pharmaceuticals

The main advantage of trading using opposite Morgan Stanley and Foresee Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Foresee Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will offset losses from the drop in Foresee Pharmaceuticals' long position.

The idea behind Morgan Stanley Direct and Foresee Pharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.